Results 201 to 210 of about 512,272 (346)
Progress and Challenges in the Global Elimination of Viral Hepatitis D. [PDF]
Li M, Wang Q, Cao W, Xie Y.
europepmc +1 more source
Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley +1 more source
Data to Monitor Viral Hepatitis Elimination in the United States. [PDF]
Casillas SM, Hoots BE, Gupta N.
europepmc +1 more source
PRISMA study flow diagram. ABSTRACT Introduction Advances in HIV management have transformed HIV into a chronic condition, resulting in improved prognosis and increased survival among people living with HIV (PLWH). Traditional risk factors for metabolic dysfunction‐associated steatotic liver disease (MASLD)—including dyslipidemia—are prevalent in PLWH.
Yovita Hartantri +6 more
wiley +1 more source
Viral Hepatitis Surveillance in the United States: Then, Now, and Looking Forward. [PDF]
Jiles RB +4 more
europepmc +1 more source
Atypical Clinical Manifestation of Acute Viral Hepatitis A among Children
Shafqat Ali +3 more
openalex +1 more source
Conformational Trajectory of the Molecular Chameleon Grazoprevir from Formulation to Target‐Bound
ABSTRACT Macrocycles represent a promising class of beyond‐rule‐of‐5 (bRo5) therapeutics, capable of targeting proteins traditionally considered undruggable by conventional small molecules. Macrocycles exhibit intrinsic flexibility and often display a “chameleon‐like” ability to adapt to their environment, thereby enhancing their oral bioavailability ...
Lianne H. E. Wieske +5 more
wiley +1 more source
HIV, Viral Hepatitis, and Schistosomiasis Association with Liver Cancer: A Systematic Review. [PDF]
Canham K +4 more
europepmc +1 more source

